Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-15

Clinical Trial Update: Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study comparing Ketamine-Assisted Psychotherapy (KAP) to ketamine alone for Major Depressive Disorder, with curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Major Depressive Disorder | Phase 2 | Status: RECRUITING